Shady Grove Fertility Reproductive Science Center Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02254577
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shady Grove Fertility Reproductive Science Center

Active Ingredients

Drugs in Phase 4 Trials (1)

progesterone (progestasert) (1 trial)

Drugs in Phase 1 Trials (1)

ketorolac (acuvail) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2